We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZEK
276
DELISTED
The AZEK Co
AZEK
| $42.1M | 0.08% |
1,694,636
+952,100
| +128% | +$30M |
|
277
Elastic
ESTC
$6.1B
| $42.1M | 0.08% |
+473,028
| New | +$42.3M |
|
278
FuboTV Inc
FUBO
$245M
| $41.7M | 0.08% |
529,534
+246,942
| +87% | +$28.8M |
|
279
Crown Castle
CCI
$32.7B
| $41.3M | 0.08% |
223,890
+208,707
| +1,375% | +$37.2M |
|
280
Huazhu Hotels Group
HTHT
$12.4B
| $40.9M | 0.08% |
1,241,239
+847,169
| +215% | +$31.4M |
|
281
PepsiCo
PEP
$186B
| $40.7M | 0.08% |
243,243
+238,535
| +5,067% | +$40M |
|
282
Truist Financial
TFC
$63.2B
| $40.7M | 0.08% |
718,096
+617,627
| +615% | +$38.1M |
|
283
Applied Materials
AMAT
$426B
| $40.5M | 0.08% |
307,607
+236,787
| +334% | +$32.6M |
|
284
Applovin
APP
$132B
| $40.2M | 0.08% |
729,758
-102,012
| -12% | -$6.49M |
|
285
Performance Food Group
PFGC
$17.5B
| $40.1M | 0.08% |
788,559
-49,959
| -6% | -$2.45M |
|
286
MakeMyTrip
MMYT
$4.67B
| $39.9M | 0.08% |
1,488,585
+110,880
| +8% | +$2.86M |
|
287
US Foods
USFD
$21.4B
| $39.8M | 0.08% |
1,057,238
-1,152,115
| -52% | -$42M |
|
|
SWTX
288
DELISTED
SpringWorks Therapeutics
SWTX
| $39.8M | 0.08% |
704,597
+297,078
| +73% | +$17M |
|
|
CRHC
289
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $39.5M | 0.07% |
3,974,238
+204,641
| +5% | +$2.02M |
|
290
Silicon Motion
SIMO
$9.19B
| $39.4M | 0.07% |
589,650
+330,608
| +128% | +$25.8M |
|
291
Tower Semiconductor
TSEM
$26.4B
| $39.3M | 0.07% |
+811,747
| New | +$34.2M |
|
292
Steven Madden
SHOO
$3.12B
| $39.3M | 0.07% |
1,016,230
-199,342
| -16% | -$8.24M |
|
293
ExxonMobil
XOM
$651B
| $39.2M | 0.07% |
475,115
-316,736
| -40% | -$24.6M |
|
294
Carrier Global
CARR
$57.2B
| $38.7M | 0.07% |
844,600
-241,196
| -22% | -$11.4M |
|
295
PUT
Netflix
NFLX
$292B
| $38.4M | 0.07% |
1,026,000
+147,000
| +17% | +$6.12M |
|
296
Colgate-Palmolive
CL
$72.6B
| $38.3M | 0.07% |
505,665
+442,472
| +700% | +$35M |
|
297
Kimberly-Clark
KMB
$36.4B
| $38.3M | 0.07% |
310,861
+310,686
| +177,535% | +$41M |
|
|
CPUH
298
DELISTED
Compute Health Acquisition Corp.
CPUH
| $38.2M | 0.07% |
3,910,246
+152
| +0% | +$1.48K |
|
299
LivaNova
LIVN
$4.3B
| $37.8M | 0.07% |
461,729
| – | – |
|
300
Datadog
DDOG
$87.9B
| $37.7M | 0.07% |
248,719
-217,281
| -47% | -$31.8M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.